170 related articles for article (PubMed ID: 19013493)
1. Forecasting demand for Hib-containing vaccine in the world's poorest countries: a 4-year prospective experience.
Zuber PL; Dumolard L; Shirey M; Rizzo I; Marshall J
Vaccine; 2009 Jan; 27(3):410-5. PubMed ID: 19013493
[TBL] [Abstract][Full Text] [Related]
2. Progress toward introduction of Haemophilus influenzae type b vaccine in low-income countries--worldwide, 2004-2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Feb; 57(6):148-51. PubMed ID: 18272957
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.
Gessner BD
Expert Rev Vaccines; 2009 Jan; 8(1):91-102. PubMed ID: 19093776
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
Sow SO; Tapia MD; Diallo S; Keita MM; Sylla M; Onwuchekwa U; Pasetti MF; Kotloff KL; Levine MM
Am J Trop Med Hyg; 2009 Jun; 80(6):1033-8. PubMed ID: 19478272
[TBL] [Abstract][Full Text] [Related]
5. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
Gessner BD; Adegbola RA
Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
[TBL] [Abstract][Full Text] [Related]
6. Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries.
Beurret M; Hamidi A; Kreeftenberg H
Vaccine; 2012 Jul; 30(33):4897-906. PubMed ID: 22683521
[TBL] [Abstract][Full Text] [Related]
7. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
8. Vaccine-preventable haemophilus influenza type B disease burden and cost-effectiveness of infant vaccination in Indonesia.
Gessner BD; Sedyaningsih ER; Griffiths UK; Sutanto A; Linehan M; Mercer D; Mulholland EK; Walker DG; Steinhoff M; Nadjib M
Pediatr Infect Dis J; 2008 May; 27(5):438-43. PubMed ID: 18398383
[TBL] [Abstract][Full Text] [Related]
9. [Global challenges of Haemophilus vaccinations quarter of a century after the Hib project].
Eskola J; Black S
Duodecim; 2010; 126(9):1047-54. PubMed ID: 20593628
[TBL] [Abstract][Full Text] [Related]
10. Introducing new vaccines in developing countries: concepts and approaches to estimating burden of Haemophilus influenzae type b-associated disease.
Kilgore PE; Nyambat B
J Health Popul Nutr; 2004 Sep; 22(3):246-56. PubMed ID: 15609777
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of oropharyngeal colonization by Haemophilus influenzae type b in Iranian children.
Karimi A; Alborzi A; Fahimzad A; Gooya M; Esteghamati A; Armin SH; Fallah F
East Mediterr Health J; 2009; 15(3):544-8. PubMed ID: 19731770
[TBL] [Abstract][Full Text] [Related]
12. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
Hajjeh RA; Privor-Dumm L; Edmond K; O'Loughlin R; Shetty S; Griffiths UK; Bear AP; Cohen AL; Chandran A; Schuchat A; Mulholland EK; Santosham M
Vaccine; 2010 Oct; 28(43):7123-9. PubMed ID: 20659515
[TBL] [Abstract][Full Text] [Related]
13. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
[TBL] [Abstract][Full Text] [Related]
14. Epiglottitis in Sydney before and after the introduction of vaccination against Haemophilus influenzae type b disease.
Wood N; Menzies R; McIntyre P
Intern Med J; 2005 Sep; 35(9):530-5. PubMed ID: 16105154
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
Broughton EI
J Public Health (Oxf); 2007 Dec; 29(4):441-8. PubMed ID: 17875589
[TBL] [Abstract][Full Text] [Related]
16. Burden of invasive disease caused by Haemophilus influenzae type b (Hib) in Africa.
Bröker M
Minerva Pediatr; 2008 Jun; 60(3):337-42. PubMed ID: 18487979
[TBL] [Abstract][Full Text] [Related]
17. Accelerating Haemophilus influenzae type b vaccine introduction in the world's poorest countries: a dream is coming true.
O'Loughlin RE; Hajjeh R
Future Microbiol; 2008 Aug; 3(4):377-8. PubMed ID: 18651806
[No Abstract] [Full Text] [Related]
18. [Increase in the number of invasive Haemophilus influenzae type b infections].
Spanjaard L; van den Hof S; de Melker HE; Vermeer-de Bondt PE; van der Ende A; Rijkers GT
Ned Tijdschr Geneeskd; 2005 Dec; 149(49):2738-42. PubMed ID: 16375019
[TBL] [Abstract][Full Text] [Related]
19. Immunization against Haemophilus influenzae type b in Sweden--a study of the introduction process.
Garpenholt O; Fredlund H; Timpka T
Scand J Public Health; 2001 Dec; 29(4):271-8. PubMed ID: 11775783
[TBL] [Abstract][Full Text] [Related]
20. [Nasopharyngeal Hib Carriage Among Healthy Children Attending Daycare Centers in Yokohama After One Year of a Publicly Funded Vaccine Program].
Saito A; Sumita H; Minohara Y; Fujita S; Yazaki S; Kitamura M; Kawai S; Kamata K; Oota Y; Yamada M; Matsumoto Y; Takeyasu N
Kansenshogaku Zasshi; 2015 Jan; 89(1):30-6. PubMed ID: 26548294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
